Guilherme Sobreira Spina

Guilherme Sobreira Spina

Auto-generated profile, based on publicly available information

Guilherme Sobreira Spina

Universidade de São Paulo

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2020 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
FTFlavio Tarasoutchi
Flavio Tarasoutchi
MMMarcelo Westerlund Montera
Marcelo Westerlund Montera
ARAuristela Isabel de Oliveira Ramos
Auristela Isabel de Oliveira Ramos
RSRoney Orismar Sampaio
Roney Orismar Sampaio
VRVitor Emer Egypto Rosa
Vitor Emer Egypto Rosa
JSJose Saraiva
Jose Saraiva
1. Introduction There are currently a wide modalities of interventional strategies – both transcatheter and surgical – which can be indicated for patients with valvular heart diseases (VHD), with the objective of reducing the morbidity and mortality. The correct timing for indication and the type of interventional treatment are linked to the precise anatomical and functional diagnosis of the VHD, and comprehensive global evaluation of the patient. The 2020 Update of the Brazilian Guidelines for VHD, in addition to compiling [...] 1. Introduction There are currently a wide modalities of interventional strategies – both transcatheter and surgical – which can be indicated for patients with valvular heart diseases (VHD), with the objective of reducing the morbidity and mortality. The correct timing for indication and the type of interventional treatment are linked to the precise anatomical and functional diagnosis of the VHD, and comprehensive global evaluation of the patient. The 2020 Update of the Brazilian Guidelines for VHD, in addition to compiling

1 August 2009 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
PLPaulo de Lara Lavítola
Paulo de Lara Lavítola
GSGuilherme Sobreira Spina
Guilherme Sobreira Spina
RSRoney Orismar Sampaio
Roney Orismar Sampaio
FTFlavio Tarasoutchi
Flavio Tarasoutchi
MGMax Grinberg
Max Grinberg
Bleeding is one of the main concerns in patients undergoing oral anticoagulation therapy. To investigate the determinant causes of bleeding in patients undergoing oral anticoagulant therapy. A total of 360 patients with atrial fibrillation (AF) undergoing oral anticoagulant (ACo) therapy, with a target INR of 2.0-3.5, were followed prospectively for a period of 48 +/- 7.2 months. The patients were evaluated on average every 30 days and were investigated regarding the presence of associated pathology that could lead to bleeding. A total of 338 patients participated in the present study. Of these, 210 (62.13%) were females. Mitral stenosis was present in 218 patients (64.4%), a mitral biological prosthesis in 64 (18.9%) and mitral valve failure in 56 (16.5%) patients. Bleeding occurred in 65 patients (19.2%), being severe in 7 (10%) patients. In 38/65 patients, a new associated disease was identified, which facilitated bleeding. An associated disease was identified in 100% of the patients with bleeding within the therapeutic range, against 49.05% of associated disease diagnosis in those with an INR > 3.5 (p=0.001). The diagnosis of a local disease associated to the bleeding was frequent among those patients undergoing oral anticoagulant therapy (58.5%). There was an association between bleeding with an INR within the therapeutic range (INR=2.0-3.5) and the diagnosis of a pathology predisposing to bleeding (p<0.001). It is mandatory to investigate the cause of bleeding in patients undergoing oral anticoagulant therapy, especially if the INR is within the therapeutic range.

1 February 2012 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
ASAlexandre De Matos Soeiro
Alexandre De Matos Soeiro
MAMaria Carolina Feres de Almeida
Maria Carolina Feres de Almeida
TATarso Augusto Duenhas Accorsi
Tarso Augusto Duenhas Accorsi
GSGuilherme Sobreira Spina
Guilherme Sobreira Spina
CJCarlos Vicente Serrano Junior
Carlos Vicente Serrano Junior
FTFlavio Tarasoutchi
Flavio Tarasoutchi
We report on a 30-year-old female patient, with biological mitral valve prosthesis due to symptomatic mitral stenosis and a history of acute myocardial infarction and generalized tonic-clonic seizure episodes, visual hallucinations, cerebral thromboembolic events and, at present, chorea and acute carditis. The patient was diagnosed with active rheumatic fever (RF), systemic lupus erythematosus (SLE) and Antiphospholipid syndrome (APS). The combination of three unusual diagnoses in the same patient makes this a unique case, modifying patient treatment and prognosis.

1 September 2009 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
RSRoney Orismar Sampaio
Roney Orismar Sampaio
FJFrancisco Costa da Silva Jr.
Francisco Costa da Silva Jr.
IOIraí Santana de Oliveira
Iraí Santana de Oliveira
CPCelso Madeira Padovesi
Celso Madeira Padovesi
JSJoyce Aparecida Soares
Joyce Aparecida Soares
MGMax Grinberg
Max Grinberg
Prosthetic valve leak is a possible complication of surgical valve replacement. Although uncommon, its consequences may be serious. Few studies correlate the degree of prosthetic valve leak with clinical events. To compare the postoperative outcome of patients with mild/moderate (Mi/Mo) or severe (Sev) prosthetic valve leak A total of 185 patients with prosthetic valve leak were selected among 1350 patients undergoing heart valve surgery between 1999 and 2001. Of these, a sample of 58 patients (37 men) with prosthetic valve leak (36 with Mi/Mo versus 22 with Sev leak) in the pre and/or postoperative period of heart valve replacement had complete medical record data, so their clinical, laboratory and echocardiographic data could be retrospectively assessed. The incidence of reoperation was 11.1% in the Mi/Mo group, versus 22.7% in the Sev group (odds ratio = 2.35 [95% CI 0.56-9.94]). Endocarditis was the cause of reoperation in 75% of the patients of the Mi/Mo group and in 60% of the Sev group. Aortic bioprostheses were those most frequently related to leak (55.8% in the Mi/Mo group and 57.7% in the Sev group). Forty percent of the patients with previous Mi/Mo leak did not present prosthetic valve leak on postoperative day 2 versus 21.4% of the patients with Sev prosthetic valve leak. No significant differences were found regarding laboratory variables. (1) Patients with severe leak are more likely to undergo reoperation. (2) Endocarditis was the most frequent cause of reoperation for any leak degree. (3) Severe prosthetic valve leak is more difficult to fully resolve after surgical treatment.

1 January 2026 in AME Case Reports
Verified
Journal Article
Open access
PDF file
PCPedro Calomeni
Pedro Calomeni
ECEduardo Sorice Correa
Eduardo Sorice Correa
DADaniel Souza Araujo
Daniel Souza Araujo
GSGuilherme Sobreira Spina
Guilherme Sobreira Spina
Background: Spontaneous intramural small bowel hematoma (SISBH) is a rare complication of long-term oral anticoagulation, particularly with vitamin K antagonists (VKAs). SISBH diagnosis is based on oral anticoagulation history associated with acute abdominal symptoms and suggestive radiological findings. Experience with this condition is still limited in the literature. This report highlights the clinical presentation and management of this rare condition, including the first known use of total-body positron emission tomography/computed tomography (PET/CT) scan in the diagnostic workup of SISBH. Case Description: A 53-year-old male on long-term oral anticoagulation with VKA for mechanical mitral valve replacement due to rheumatic heart disease presented to the emergency department for abdominal pain and nausea. Physical examination was remarkable for abdominal distension, increased bowel sounds and rebound tenderness, a presentation compatible with intestinal subocclusion. At admission, the international normalized ratio was 8.3, indicating VKA intoxication. Abdominal CT revealed significant jejunal parietal thickening, suggestive of SISBH. PET/CT findings were also consistent with a possible hematoma, although an inflammatory or neoplastic process could not be excluded. We opted for conservative treatment with temporary warfarin suspension and vitamin K infusion. The patient’s intestinal subocclusion gradually improved, and he was discharged after seven days with full recovery. Conclusions: SISBH, although rare, should be considered in the differential diagnosis of acute abdominal symptoms in patients receiving long-term oral anticoagulation, particularly with VKAs. Conservative treatment is the preferred initial option. A high index of suspicion, followed by prompt abdominal CT, is key to early diagnosis. PET/CT provided minimal diagnostic value beyond CT. Conservative management with anticoagulation reversal and supportive care is generally the primary therapeutic strategy adopted in the literature, demonstrating favorable short-term outcomes, as was the case with our patient.

14 January 2026 in Global Heart
Verified
Journal Article
Open access
PDF file
LSLeonardo Dexheimer da Silva
Leonardo Dexheimer da Silva
JFJoão Luís Freitas
João Luís Freitas
FPFelipe Dircêu Dantas Leite Pessôa
Felipe Dircêu Dantas Leite Pessôa
EVElinthon Tavares Veronese
Elinthon Tavares Veronese
CBCarlos Manuel de Almeida Brandão
Carlos Manuel de Almeida Brandão
FTFlavio Tarasoutchi
Flavio Tarasoutchi
Background: Heart valve disease is a growing cause of mortality and disability worldwide, disproportionately burdening low- and middle-income countries (LMICs), where rheumatic heart disease remains a major etiology and cardiac surgical capacity covers less than 2% of the estimated need. Population-level outcome data after valve surgery in LMICs are virtually absent. We leveraged Brazil’s universal health system to quantify how income, geography, and disease etiology are associated with survival after valve replacement surgery. Methods: Five Brazilian public health databases covering outpatient care (SIA), hospital admissions (SIH), mortality records (SIM), the cancer registry (RHC), and a social vulnerability index (IVS Atlas) were linked to a single individual-level longitudinal record, with a proof-of-life algorithm correcting right-censoring bias. All patients undergoing valve replacement surgery between January 2015 and December 2024 were included. Results: Among 63,426 patients (mean age 56.9 ± 15.2 years; median follow-up 1,023 days), the in-hospital mortality rate was 8.6% and the five-year mortality was 30.1%. Income and geography were significantly associated with survival: the highest income quartile had significantly lower mortality than the lowest quartile in the adjusted Cox model (HR 0.82; 95% CI 0.76–0.89; p < 0.001), and in-hospital mortality exceeded 25% in low-volume municipalities in the North region. Valve lesion subtype predicted outcomes differentially across time horizons, and reoperation was associated with worse survival (HR 1.48; 95% CI 1.37–1.58; p < 0.001). Conclusion: Income, geography, and valve-specific risk factors are important factors associated with survival after valve surgery in Brazil’s public health system, reflecting structural conditions shared across LMICs. The linkage framework offers a scalable model for cardiovascular outcome surveillance in resource-constrained settings. Lay Summary Each year, thousands of Brazilians undergo heart valve surgery through the public health system. Using data from over 63,000 patients treated between 2015 and 2024, we found that survival after valve surgery in Brazil is substantially worse than in wealthier countries and that outcomes differ markedly depending on which valve is affected and why. Patients who required a second surgery fared worse, and those living in regions with fewer surgical centers faced higher mortality. These findings highlight critical gaps in cardiac surgical care, which can guide resource allocation and policy in Brazil and similar settings.